EIF5A2 is a novel chemoresistance gene in breast cancer (Q39014521)

8 September 2017

title

EIF5A2 is a novel chemoresistance gene in breast cancer (English)

1 reference

8 September 2017

Yu Liu

1

1 reference

8 September 2017

Feiya Du

2

1 reference

8 September 2017

Wei Chen

3

1 reference

8 September 2017

Minya Yao

4

1 reference

8 September 2017

Kezhen Lv

5

1 reference

8 September 2017

Peifen Fu

6

1 reference

8 September 2017

publication date

18 March 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

22

1 reference

8 September 2017

issue

6

1 reference

8 September 2017

page(s)

602-607

1 reference

Targeting oncogenes to improve breast cancer chemotherapy

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Oncogenic role of eIF-5A2 in the development of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Translation initiation factor 5A and its hypusine modification are essential for cell viability in the yeast Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Identification of mRNA that binds to eukaryotic initiation factor 5A by affinity co-purification and differential display

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Pkc1 acts through Zds1 and Gic1 to suppress growth and cell polarity defects of a yeast eIF5A mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Identification of a new member of the human eIF-5A gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Identification and characterization of eukaryotic initiation factor 5A-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-014-0526-2

10.1007/S12282-014-0526-2

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference